Legend Biotech Corp - COMMON STOCK (LEGN)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
367,291,225
Total 13F shares
52,424,985
Share change
+1,640,338
Total reported value
$2,882,767,418
Put/Call ratio
42%
Price per share
$55.00
Number of holders
145
Value change
+$117,157,835
Number of buys
79
Number of sells
70

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q2 2022

As of 30 Jun 2022, Legend Biotech Corp - COMMON STOCK (LEGN) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,424,985 shares. The largest 10 holders included FMR LLC, HHLR ADVISORS, LTD., BlackRock Inc., Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, FEDERATED HERMES, INC., Artisan Partners Limited Partnership, JOHNSON & JOHNSON, and ALLIANCEBERNSTEIN L.P.. This page lists 146 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.